Dietary regulation of type 2 immunity and inflammation in the gut

肠道 2 型免疫和炎症的饮食调节

基本信息

项目摘要

PROJECT SUMMARY Understanding the role of environmental factors including signals derived from the diet and microbiota is key to improving therapeutic and intervention strategies for gastrointestinal disorders including inflammatory bowel diseases (IBD) and inflammation-associated colorectal cancer (CRC). Dietary fiber can exert immunoregulatory effects through microbial fermentation products including short chain fatty acids (SCFAs). However, the influence of dietary fiber on most microbiota-derived metabolites and their role in immunoregulation remain unclear. In new preliminary studies, I identified that an inulin-rich high fiber diet triggers colonic eosinophilia in a microbiota- dependent manner which exacerbates disease outcomes in murine models of intestinal damage and inflammation-associated CRC. These diet-induced type 2 inflammatory responses are associated with upregulation of microbiota-derived bile acids and activation of mesenchymal stromal cells (MSCs) and group 2 innate lymphoid cells (ILC2s). However, the cellular and molecular components in the host and the metabolic pathways in the microbiota that mediate the dietary effects on intestinal inflammation remain unclear. In Aim 1, I will determine how bile acids regulate type 2 cytokines and eosinophilia during high fiber diet-induced intestinal inflammation. In Aim 2, I will investigate how dietary fiber-induced eosinophils contribute to intestinal damage. In Aim 3, I will employ bacterial genetics and gnotobiotic approaches to identify the microbial metabolic pathways required for high fiber diet-induced intestinal inflammation. Upon successful completion of the proposed aims, I expect to contribute to a fundamentally new understanding of the biology of dietary fiber, microbiota-derived metabolites, and stromal cells in regulating type 2 inflammation which could contribute to rational design of diet- and microbiota-based therapeutic approaches. My overarching career goals are to become an independent investigator and an inspirational mentor at a leading academic institution and to study the mechanisms by which environmental factors regulate intestinal inflammation and gastrointestinal diseases. Completion of my research aims in this proposal will allow me to develop various scientific, professional, and personal skills critical to become a successful independent investigator. These will include acquiring expertise in various fields including metabolomic analyses and genetic engineering with help of my collaborators, as well as developing skills in writing, mentoring, communicating and laboratory management. I will perform the K99 phase in the laboratory of Dr. David Artis, a world leader in the fields of mucosal immunology and host-microbiota interactions. The laboratory has access to all instruments and facilities necessary to complete the proposed aims including a gnotobiotic animal facility and provides an outstanding environment and training program to support postdoctoral researchers. In addition to my mentor and co-mentor, I have support from several distinguished investigators with extensive expertise as advisors and collaborators that will greatly facilitate the completion of my experiments during the K99 phase as I progress to become an independent investigator.
项目摘要 了解环境因素的作用,包括饮食和菌群衍生的信号是至关重要的 改善胃肠道疾病(包括炎症性肠)的治疗和干预策略 疾病(IBD)和炎症相关结直肠癌(CRC)。饮食纤维可以发挥免疫调节性 通过微生物发酵产物(包括短链脂肪酸(SCFA))的影响。但是,影响 大多数微生物群的饮食纤维及其在免疫调节中的作用尚不清楚。在 我确定了新的初步研究,发现一种富含浓度蛋白的高纤维饮食会触发微生物群中的结肠嗜酸性粒细胞。 在肠道损伤和 炎症相关的CRC。这些饮食引起的2型炎症反应与 微生物源衍生的胆汁酸的上调以及间质基质细胞(MSC)和2组的激活 先天淋巴样细胞(ILC2S)。但是,宿主和代谢中的细胞和分子成分 介导饮食对肠道炎症影响的微生物群中的途径尚不清楚。在AIM 1中, 我将确定在高纤维饮食诱导的肠道期间如何调节2型细胞因子和嗜酸性粒细胞 炎。在AIM 2中,我将研究饮食纤维诱导的嗜酸性粒细胞如何造成肠道损伤。 在AIM 3中,我将采用细菌遗传学和gnotobiotic方法来识别微生物代谢途径 高纤维饮食引起的肠炎所必需的。成功完成拟议的目标后,我 期望有助于对饮食纤维的生物学产生新的理解 代谢物和基质细胞调节2型炎症,这可能有助于饮食的合理设计 和基于微生物群的治疗方法。我的总体职业目标是成为一个独立的目标 领先的学术机构的研究者和鼓舞人心的导师,并研究了该机制 环境因素调节肠道炎症和胃肠道疾病。完成我的研究 该提案的目标将使我能够发展出至关重要的各种科学,专业和个人技能 成为成功的独立调查员。这些将包括在包括 代谢组分析和基因工程在我的合作者的帮助下以及发展技能 写作,指导,沟通和实验室管理。我将在实验室执行K99阶段 戴维·阿蒂斯(David Artis)博士,粘膜免疫学领域的世界领导者和宿主 - 微生物互动。这 实验室可以使用所有必要的工具和设施来完成拟议的目标,包括 gnotobiotic动物设施,并提供了一个出色的环境和培训计划,以支持博士后 研究人员。除了我的导师和联合学者外,我还得到了几位杰出调查员的支持 作为顾问和合作者的广泛专业知识,将极大地促进我的实验完成 在K99阶段,随着我的发展成为独立研究者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mohammad Arifuzzaman其他文献

Mohammad Arifuzzaman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
  • 批准号:
    10836298
  • 财政年份:
    2023
  • 资助金额:
    $ 9.88万
  • 项目类别:
Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis
评估免疫检查点抑制剂与骨关节炎之间的关系
  • 批准号:
    10577306
  • 财政年份:
    2023
  • 资助金额:
    $ 9.88万
  • 项目类别:
A Fully Remote Pilot Randomized Controlled Trial to Investigate the Impact of Insomnia Treatment on Crohn’s disease
一项完全远程试点随机对照试验,研究失眠治疗对克罗恩病的影响
  • 批准号:
    10571042
  • 财政年份:
    2023
  • 资助金额:
    $ 9.88万
  • 项目类别:
Koli: A non-surgical solution for gallstone disease
Koli:胆结石疾病的非手术解决方案
  • 批准号:
    10698949
  • 财政年份:
    2023
  • 资助金额:
    $ 9.88万
  • 项目类别:
Mechanisms of Gastrointestinal COVID-19
胃肠道 COVID-19 的机制
  • 批准号:
    10538795
  • 财政年份:
    2022
  • 资助金额:
    $ 9.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了